ERD

Sort by

European Partnerships

Show in overview

EU-Programme-Call

Show in overview

9 items found

Toggle all information

UNITE4TB | ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS

01-06-2021

31-05-2028

Show more information

Organisation GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

01-01-2020

31-12-2025

Show more information

Organisation GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

GNA NOW | NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW

01-07-2019

31-12-2025

Show more information

Organisation GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

NAVIPP | New AntiVirals for Infections with Pandemic Potential

01-01-2024

31-12-2028

Show more information

Organisation GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

ITHEMYC | Novel immunotherapies for tuberculosis and other mycobacterial diseases

01-06-2023

31-05-2027

Show more information

Organisation GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

PIA | Photocatalytic Industrial Applications

01-01-2025

31-12-2028

Show more information

Organisation GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

anTBiotic | AnTBiotic – progressing TB drug candidates to clinical proof of concept

01-01-2017

30-06-2022

Show more information

Organisation GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

TRIC-TB | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments.

01-05-2019

29-02-2024

Show more information

Organisation GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

LYMPHVECs | Development of lipid nanoparticles based on solid matrix for Benznidazole oral delivery targeting to the lymphatic system to treat Chagas disease

01-03-2019

31-03-2021

Show more information

Organisation GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

Projects overview

Selected filters:

UNITE4TB | ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS

ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

GNA NOW | NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW

NAVIPP | New AntiVirals for Infections with Pandemic Potential

ITHEMYC | Novel immunotherapies for tuberculosis and other mycobacterial diseases

PIA | Photocatalytic Industrial Applications

anTBiotic | AnTBiotic – progressing TB drug candidates to clinical proof of concept

TRIC-TB | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments.

LYMPHVECs | Development of lipid nanoparticles based on solid matrix for Benznidazole oral delivery targeting to the lymphatic system to treat Chagas disease